Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

786
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
786
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

699
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
699
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

17
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
17
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A reporting checklist for large language models in behavioural science.

Nature human behaviour·2026
Same author

Training-oriented framework for brachytherapy treatment planning in soft tissue sarcoma.

Brachytherapy·2026
Same author

In Reply to Shaffer et al.

Practical radiation oncology·2026
Same author

Saroglitazar 4 Mg in Metabolic Dysfunction-Associated Steatotic Liver Disease: 24-Week Results From Phase 4 Study.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

In Reply to Jordan.

International journal of radiation oncology, biology, physics·2026
Same author

Development and cross-validation of a novel multi-omic assay to assess locoregional recurrence risk and adjuvant therapy benefit in early-stage hormone receptor positive invasive breast cancer patients.

Breast cancer research : BCR·2026

相关实验视频

Updated: Jul 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K

使用萨库比特里尔/瓦尔沙坦降低人口健康患者的医疗保健成本

Nihanth Damera1, Chirag Shah1, Bistees George1

  • 1Internal Medicine Department, Indiana University School of Medicine, Indianapolis, Indiana.

The American journal of cardiology
|June 29, 2023
PubMed
概括
此摘要是机器生成的。

萨库比特里尔/瓦尔萨坦显著降低了心力衰竭 (HF) 患者的医疗保健成本和住院治疗. 使用这种药物超过270天可以降低22%的成本,证明了它在人口健康管理中的价值.

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

459
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K

相关实验视频

Last Updated: Jul 25, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

459
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.3K

科学领域:

  • 卫生经济学 卫生经济学
  • 心脏病学 心脏病学
  • 人口健康管理 人口健康管理

背景情况:

  • 基于价值的护理模式强调成本效益和患者的结果.
  • 医疗保健经济效率比率 (HEERO) 评分系统衡量了可问责护理组织的成本效益.
  • 萨库比特里尔/瓦尔萨坦因其降低心力衰竭 (HF) 再入院和医疗保健支出的潜力而得到认可.

研究的目的:

  • 评估萨库比特里尔/瓦尔萨坦对HF患者HEERO分数和整体医疗保健支出的影响.
  • 为了比较sacubitril/valsartan与其他标准HF药物的成本效益.

主要方法:

  • 患有HF的患者被纳入人口健康队列.
  • 在每3个月的间隔内计算HEERO分数,长达一年.
  • 在不同的药物组中,医疗费用和住院日被比较,包括sacubitril/valsartan,spironolactone,β-阻断剂 (BB) 和ACE抑制剂/ARBs.

主要成果:

  • 超过270天的sacubitril/valsartan使用与HEERO分数和住院日数的降低相关,表明医疗保健成本降低 (p < 0.0001).
  • 随着270天以上的萨库比特里尔/瓦尔萨坦使用,医疗保健费用减少了22%,主要是由于住院病例减少.
  • 在男性患者中,sacubitril/valsartan,spironolactone和BB的组合显示,与标准ACE抑制剂/ARB疗程相比,HEERO得分有所改善,住院日数减少.

结论:

  • 在人口健康环境中,在270天以上使用萨库比特里尔/瓦尔萨坦显著降低了HF患者的医疗保健支出.
  • 经济效益主要来自于减少住院治疗,这突显了萨库比特里尔/瓦尔萨坦在高价值,低成本护理中的作用.
  • 付款人应考虑补贴萨库比特里尔/瓦尔沙坦,以支持基于价值的护理,并改善患者的经济福祉.